Professional Documents
Culture Documents
SOP For Change Control - Pharmaceutical Guidelines
SOP For Change Control - Pharmaceutical Guidelines
1.0 OBJECTIVE
To lay down a procedure to define the mechanism for the initiate, review and authorization of changes in all master documents, master system and
their control.
2.0 SCOPE
This procedure applies to handle the change control at the manufacturing facility.
3.0 RESPONSIBILITY
3.1 Executive –Quality assurance - Prepare the SOP and follow-up the SOP accordingly
3.2 Asst. manager –Quality assurance & Regulatory affairs -Provide the support to the implementation of SOP and maintained the records.
4.0 ACCOUNTABILITY
4.1 Technical - Director.
5.0 PROCEDURE
5.1 This procedure is applicable to, but is not necessarily limited to all authorized documents/procedure including Validation protocols, Master
formula records, Batch manufacturing records, Standard Operating procedure, Finish product specification, Standard testing procedure, Raw
material specification, Packaging material specification.
5.2 Initial of change (s)
5.2.1 No “authorized” document can be changes without being duly authorized in accordance with this procedure
5.2.2 Each document change request must be initiated by completion of a change control form (CCF) as per Annexure –II.
5.2.3 The Asst. manager of Quality assurance & Regulatory affairs has the responsibility for controlling and tracking the CCF.
5.2.4 The user department shall initiate the changes required by filling and submitted CCF from along with supporting documents to QA department.
5.2.5 Changes to be established must have sound/ scientific justification.
5.2.6 The impact of any proposed change on the quality of the final product must be fully evaluated and documented.
Delhi to Leh
₹2,842
Ad Goibibo
Learn more
5.2.7 Quality assurance will assign a CCF No. for the documentation.
5.2.8 CCF numbering system: It contains combination of 8 digit and letters.
e.g. XYZ/CC-XXXX
Where XYZ - stands for company initial
CC - Change control
XXXX – 1st X stands for last digit of current year & next 3X’s stands for serial No.
XYZ/CC - 18001 will be CCF No. for 1st change control of the year 2018.
5.3 Management review and approval
5.3.1 Circulate the CCF together with supporting documentation, to the Head – Quality assurance & Regulatory affairs, R&D, Production, Quality
control and Warehouse as appropriate for their review and comments. Cost/ Productivity improvements must be fully justified and counter signed by
the Plant Head/ Technical Director.
5.4 Review and authorized process
5.4.1 Submit CCF documents to Quality assurance for review and authorization before implementation.
5.4.2 The Head of Quality assurance & Regulatory affairs must assign a category of change to each CCF.
5.4.3 Category ‘A’ - No regulatory impact.
Category ‘B’ - Minor changes (Notification to the Regulatory authorities required)
Category ‘C’ - Major change/s that (Approval from the Regulatory authorities is required before implementation.)
5.4.4 The review and authorised of a change shall include a sign by Head of Quality assurance & Regulatory affairs, Engineering, Quality control,
Production, Warehouse and Engineering.
5.4.5 The Head of Quality assurance & Regulatory affairs must ensure that all information (e.g. dates of submission /approval) relating to notification
to Regulatory authorities is promptly transmitted to the Departmental heads to authorized the change (if applicable) shall finally authorize all change
control (s).
https://www.pharmaguideline.com/2012/07/sop-for-change-control.html 1/4
1/20/2020 SOP for Change Control : Pharmaceutical Guidelines
5.4.6 A duly completed change control form as per Annexure- II shall be finally signed by QA dept.
5.4.7 CCF No will have stamping “CONTROLLED COPY” in red colour on right corner on each page of front side.
5.4.8 Schematic diagram of change control as per Annexure-I.
5.4.9 Issuance and controlling record will be maintained in QA department as per Annexure-III.
6.0 ABBREVIATIONS
6.1 SOP - Standard Operating Procedure
6.2 No. - Number
6.3 NA - Not Applicable
6.4 QA - Quality Assurance
6.5 CCF - Change Control Form
6.6 R&D - Research & Development
6.7 RA - Regulatory Affairs
ANNEXURE – I
(SCHEMATIC DIAGRAM OF CHANGE CONTROL)
ANNEXURE – II
CHANGE CONTROL FORM (CCF)
4.1 To be amended:
______________________________________________________________________________________________________________________
____________________________________________________
4.2 To be cancelled:
______________________________________________________________________________________________________________________
________________________________
Explore the world on sale
Ad Get ready to go on an adventure with the
Etihad Airways Global Sale.
Etihad Airways
PART – B
(TO BE FILLED BY CONCERNED DEPARTMENTS)
MANAGEMENT REVIEW
https://www.pharmaguideline.com/2012/07/sop-for-change-control.html 2/4
1/20/2020 SOP for Change Control : Pharmaceutical Guidelines
Comments Reviewed by
PART - C
(TO BE FILLED BY HEAD –QUALITY ASSURANCE & REGULATORY AFFAIRS)
ASSESSMENT AND AUTHORISATION OF CCF
14.0 QA Approval:
Signature Date
Technical Director
ANNEXURE – III
(CHANGE CONTROL LOG BOOK)
S.No. CC No. Issue Name of Originating Title of Approved Effective Verified Remark
Date of Originator Department Change or Reject Date of by QA
CCF Change Sign. /
Date
Ankur Choudhary is India's first professional pharmaceutical blogger, author and founder of Pharmaceutical Guidelines, a widely-read
pharmaceutical blog since 2008. Sign-up for the free email updates for your daily dose of pharmaceutical tips.
Need Help: Ask Question
https://www.pharmaguideline.com/2012/07/sop-for-change-control.html 3/4
1/20/2020 SOP for Change Control : Pharmaceutical Guidelines
Copyright © 2008-2020 Pharmaceutical Guidelines
Setup ❘ Terms of Use ❘ FAQ
https://www.pharmaguideline.com/2012/07/sop-for-change-control.html 4/4